Toremifene citrate, Catalog: B1049

IN STOCK!
US$0.00

(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine, Acapodene, Fareston, GTx 006, Z-Toremifene

PRODUCT SUMMARY

Alternate Names (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine, Acapodene, Fareston, GTx 006, Z-Toremifene

Appearance White to off-white solid

CAS # 89778-27-8

Molecular Formula C₂₆H₂₈ClNO.C₆H₈O₇

Molecular Weight 598.08

Purity ≥ 98% by HPLC

Solubility DMSO (>10 mg/ml)

SMILES CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

InChi InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;

InChi Key IWEQQRMGNVVKQW-OQKDUQJOSA-N

PubChem CID 3005572

MDL Number MFCD01729016

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Toremifene citrate is a selective estrogen receptor modulator (SERM) that is widely being used as endocrine therapy for estrogen receptor positive breast cancer. Toremifene citrate is known to increase bone mineral density in prostate cancer patients undergoing